Upadacitinib APIs by Loncom Pharma represent a new generation of Janus kinase inhibitors, providing relief for autoimmune conditions such as rheumatoid arthritis. These APIs offer a new hope for patients with moderate to severe cases, where other treatments may not have been effective.
| Name | Size | Update | Download |
|---|---|---|---|
| Biocom/Loncom FDF Product List.pdf | 991KB | 2026-04-14 | Download |
| Biocom/Loncom API Product List.pdf | 903KB | 2026-04-14 | Download |
| Loncom Intermediate List.pdf | 4.69MB | 2026-01-22 | Download |
